Playback speed
10 seconds
How I Treat Unfit/Frail MM Patients: Is Frailty Measurable and Do Novel Agents Increase Survival Rates? Is Chemoimmunotherapy the Best Option for Fit Patients?
By
2nd SOHO Italian Conference
FEATURING
Daniele Derudas
By
2nd SOHO Italian Conference
FEATURING
Daniele Derudas
5 views
January 25, 2021
Login to view comments.
Click here to Login